CUSIP: 30048L104
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,528,280
-
Share change
-
-3,359,320
-
Total reported value
-
$8,833,925
-
Put/Call ratio
-
38%
-
Price per share
-
$0.38
-
Number of holders
-
46
-
Value change
-
-$1,878,761
-
Number of buys
-
14
-
Number of sells
-
27
Quarterly Holders Quick Answers
What is CUSIP 30048L104?
CUSIP 30048L104 identifies EVFM - EVOFEM BIOSCIENCES INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 30048L104:
Institutional Holders of EVOFEM BIOSCIENCES INC - COM (EVFM) as of Q4 2021
As of 31 Dec 2021,
EVOFEM BIOSCIENCES INC - COM (EVFM) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,528,280 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, FIRST WILSHIRE SECURITIES MANAGEMENT INC, GSA CAPITAL PARTNERS LLP, MILLENNIUM MANAGEMENT LLC, and GROUP ONE TRADING, L.P..
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.